Pharma Journalist -

Eli Lilly and Company and Avidity Biosciences, Inc. announced a global licensing and research collaboration focused on the discovery, development and commercialization of potential new…
Read More...

Teva Pharmaceutical Industries Ltd. announced the launch of a generic version of VESIcare ®1 (solifenacin succinate) Tablets, 5 mg and 10 mg, in the U.S. Solifenacin Succinate…
Read More...

Pfizer Inc. and Eli Lilly and Company announced top-line results from a Phase 3 study evaluating tanezumab 2.5 mg and 5 mg. The objective of the study was to compare the long-term joint…
Read More...

Non-profit drug developer, TB Alliance, and pharmaceutical company, Mylan N.V. announced a global collaboration to make the experimental drug pretomanid accessible for use in two…
Read More...

Ipsen and Clementia Pharmaceuticals announced the closing of Ipsen’s acquisition of Clementia following approval of the arrangement by Clementia shareholders and the Quebec Superior…
Read More...

Significant increase in exhibitors driven by bio growth at bioLIVE and separate nutraceuticals event. Shanghai, 8th April 2019: CPhI & P-MEC China (#CPhIChina and #PMECChina) –…
Read More...

SK Biopharmaceuticals, a pharmaceutical company focused on disorders of central nervous system and cancer, and twoXAR, Inc., an artificial intelligence (AI)-driven biopharmaceutical…
Read More...

PureTech Health plc, an advanced biopharmaceutical company developing novel medicines for dysfunctions of the Brain-Immune-Gut (BIG) axis, announced that it has entered into a research…
Read More...

CASI Pharmaceuticals, a U.S. pharmaceutical company with a platform to develop and accelerate the launch of innovative therapeutics and pharmaceutical products in China, the U.S., and…
Read More...

STC Biologics (www.stcbiologics.com) announced that it has completed construction of a single-use mammalian GMP manufacturing facility in Newton, Massachusetts, and that it has…
Read More...